SRPT Insider Trading Activity and SEC Form 4 Filings
Trump's trades in SRPT
From his financial disclosures
$15K+
1 purchase
$31K+
3 sales
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Sale
Jun 4, 2026
Reported 79d later
$15K - $50K
Sale
Mar 30, 2026
Reported 45d later
$1K - $15K
Purchase
Mar 4, 2026
Reported 71d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
SRPT insider trading summary
Over the past 12 months, insiders at Sarepta Therapeutics, Inc. (SRPT) reported 1 sale worth $294K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $294K.
Latest SRPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 16, 2025 | Ian Michael Estepan | Chief Operating Officer | Sell | $294K (13,187 @ $22.31) |
| Mar 12, 2025 | Claude Nicaise | Insider | Sell | $248K (2,491 @ $99.64) |
| Dec 12, 2024 | Hans Lennart Rudolf Wigzell | Insider | Sell | $1.3M (10,500 @ $124.84) |
| Dec 5, 2024 | Kathryn Jean Boor | Insider | Sell | $205K (1,636 @ $125.55) |
| Aug 30, 2024 | Ian Michael Estepan | Chief Financial Officer | Sell | $822K (5,985 @ $137.36) |
| Aug 16, 2024 | Michael Andrew Chambers | Insider | Buy | $2.5M (18,284 @ $134.06) |
| Aug 16, 2024 | Michael Andrew Chambers | Insider | Buy | $1.7M (13,106 @ $133.07) |
| Aug 16, 2024 | Michael Andrew Chambers | Insider | Buy | $761K (5,648 @ $134.66) |
| Jun 25, 2024 | Ryan Edward Brown | EVP, General Counsel | Sell | $350K (2,200 @ $159.14) |
| Jun 25, 2024 | Ryan Edward Brown | EVP, General Counsel | Sell | $1.2M (7,644 @ $158.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.